Atrican 250 (Capsules) Instructions for Use
Marketing Authorization Holder
Laboratoire Innotech International (France)
Manufactured By
Innothera Chouzy (France)
ATC Code
P01AX08 (Tenonitrozole)
Active Substance
Tenonitrozole (Rec.INN registered by WHO)
Dosage Form
| Atrican 250 | Enteric-coated capsules 250 mg: 8 pcs. |
Dosage Form, Packaging, and Composition
Enteric-coated capsules soft, from yellow to yellow-brown, oval; the capsule contents are an oily homogeneous mass of gray-brown color, with a faint characteristic odor.
| 1 capsule | |
| Tenonitrozole | 250 mg |
Excipients: peanut oil – 194 mg, hydrogenated soybean oil – 6 mg, soy lecithin – 5 mg.
Capsule shell composition: gelatin – 134 mg, sorbitol and sorbitans solution – 66 mg, titanium dioxide (E171) – 1.5 mg, yellow iron oxide dye (E172) – 1 mg, glycerol – 3.5 mg, hypromellose phthalate – 30 mg, dibutyl phthalate – 5.2 mg.
8 pcs. – blisters (1) – cardboard packs.
Clinical-Pharmacological Group
Antiprotozoal drug used for trichomoniasis
Pharmacotherapeutic Group
Antiprotozoal agent
Pharmacological Action
Antitrichomonal agent. Tenonitrozole is active against Trichomonas vaginalis. It has a trichomonacidal effect. Also active against Candida albicans.
Pharmacokinetics
Well absorbed from the gastrointestinal tract. Slowly excreted.
Indications
Trichomoniasis of the genitourinary system (in women and men).
ICD codes
| ICD-10 code | Indication |
| A59 | Trichomoniasis |
| N37.0 | Urethritis in diseases classified elsewhere |
| N77.1 | Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere |
| ICD-11 code | Indication |
| 1A92 | Trichomoniasis |
| 1F23.10 | Candidiasis of vulva and vagina |
| 1F65 | Enterobiasis |
| 1H0Z | Unspecified infection |
| GC02.1 | Nonspecific urethritis |
| 1A94.0 | Genital or urogenital tract infection caused by Herpes simplex virus |
| GA41 | Ulcerative or erosive diseases of vulva |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally. Take one 250 mg capsule twice daily. Ingest capsules with meals to improve tolerability.
Maintain a consistent dosing schedule. The total duration of treatment is four consecutive days.
Ensure simultaneous treatment of the sexual partner to prevent reinfection. Abstain from sexual intercourse for the entire treatment course.
Swallow capsules whole. Do not crush or chew the enteric-coated capsules.
Strictly avoid consumption of alcohol and ethanol-containing medications during therapy and for several days after completion.
Complete the full prescribed course, even if symptoms improve. Do not exceed the recommended dosage or duration.
If a dose is missed, take it as soon as remembered. If it is nearly time for the next dose, skip the missed dose. Do not double the dose to catch up.
Discontinue use and consult a physician immediately if signs of hypersensitivity, such as skin rash or urticaria, appear.
Adverse Reactions
From the digestive system: nausea, epigastric discomfort, loss of appetite.
Allergic reactions: urticaria, skin rashes, itching.
Contraindications
Hypersensitivity to tenonitrozole; acute and chronic hepatic failure; childhood.
Use in Pregnancy and Lactation
During pregnancy, it can be used if indicated in cases where the intended benefit to the mother outweighs the potential risk to the fetus. If it is necessary to use during lactation, the issue of discontinuing breastfeeding should be decided.
Use in Hepatic Impairment
Contraindicated in acute and chronic hepatic failure.
Pediatric Use
Contraindicated in children and adolescents under 18 years of age.
Special Precautions
Simultaneous treatment of the sexual partner is necessary. During the course of treatment for trichomoniasis, sexual intercourse should be avoided.
During treatment with tenonitrozole, wearing contact lenses is not recommended.
Yellow discoloration of the sclera and urine is possible.
If several courses of tenonitrozole therapy have been conducted, then upon completion of treatment, monitoring of the peripheral blood picture is recommended.
During treatment, consumption of alcohol and medicines containing ethanol should be avoided.
Tenonitrozole is not recommended for simultaneous use with disulfiram.
Drug Interactions
Incompatible with medicines containing ethanol.
Storage Conditions
Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Actovegin pills 200mg, 50pcs
Noopept, pills 10mg, 50pcs
Kagocel pills 12mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs
No-spa pills 40mg, 64pcs
Daivobet, ointment, 30g
Arbidol, capsules 100mg, 40pcs
Fenotropil pills 100mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Belosalic, ointment, 30g
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs 